Gene: POLH
Official Full Name: DNA polymerase etaprovided by HGNC
Gene Summary: This gene encodes a member of the Y family of specialized DNA polymerases. It copies undamaged DNA with a lower fidelity than other DNA-directed polymerases. However, it accurately replicates UV-damaged DNA; when thymine dimers are present, this polymerase inserts the complementary nucleotides in the newly synthesized DNA, thereby bypassing the lesion and suppressing the mutagenic effect of UV-induced DNA damage. This polymerase is thought to be involved in hypermutation during immunoglobulin class switch recombination. Mutations in this gene result in XPV, a variant type of xeroderma pigmentosum. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02489 | POLH Knockout cell line (HeLa) | Human | POLH | 1:3~1:6 | Negative | Online Inquiry |
KO02490 | POLH Knockout cell line (HCT 116) | Human | POLH | 1:2~1:4 | Negative | Online Inquiry |
KO02491 | POLH Knockout cell line (HEK293) | Human | POLH | 1:3~1:6 | Negative | Online Inquiry |
KO02492 | POLH Knockout cell line (A549) | Human | POLH | 1:3~1:4 | Negative | Online Inquiry |
POLH Gene Knockout Cell Lines are highly specialized human cell models in which the polymerase theta (POLH) gene has been systematically disrupted to study its biological functions and implications. These knockout cell lines provide researchers with a critical tool to investigate the role of POLH in processes such as DNA repair, replication fidelity, and cellular response to genotoxic stress. By inactivating this gene, the cell lines enable a deeper understanding of potential pathways of tumorigenesis and sensitivity to specific chemotherapeutic agents, such as those targeting DNA repair mechanisms.
The POLH gene encodes for a DNA polymerase involved in translesion synthesis, a mechanism that allows cells to replicate past DNA lesions. By studying knockout variants, researchers can elucidate the cellular compensatory mechanisms that arise from POLH deficiency, revealing vital insights into the adaptive responses of cancer cells and their survival strategies under therapeutic pressure. This bioengineering approach has far-reaching applications in cancer research, genetics studies, and drug development.
Compared to traditional cell lines that express the POLH gene, these knockout models provide a clear advantage by removing confounding variables related to gene expression. This specificity facilitates targeted investigations, making it easier to assess the direct consequences of POLH loss on cell behavior and treatment outcomes. Moreover, the precise genetic modification ensures reliability and reproducibility, which are crucial for scientific rigor.
For researchers and clinicians focused on understanding cancer biology and treatment resistance, POLH Gene Knockout Cell Lines represent a valuable asset in the arsenal of experimental tools. Their unique capabilities support investigations that could lead to breakthroughs in personalized medicine and targeted therapies.
Our company exemplifies excellence in producing high-quality, genetically modified cell lines, backed by a team of experts dedicated to accelerating research and advancing biological science. With our POLH Gene Knockout Cell Lines, you gain access to an unparalleled research resource that empowers your scientific discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.